These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15646499)

  • 41. Retained perfluorodecalin after retinal detachment surgery.
    Wong TY; Ho T
    Int Ophthalmol; 1996-1997; 20(6):293-4. PubMed ID: 9237128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Our experience with perfluorohexyloctane (F6H8) as a temporary endotamponade in vitreoretinal surgery.
    Stefaniotou MI; Aspiotis MV; Kitsos GD; Kalogeropoulos CD; Asproudis IC; Psilas KG
    Eur J Ophthalmol; 2002; 12(6):518-22. PubMed ID: 12510721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraocular pressure changes in the vitreon study.
    Batman C; Cekiç O; Totan Y; Aslan O; Ozalp S
    Ophthalmic Surg Lasers; 1999; 30(9):721-6. PubMed ID: 10574493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NOVEL ENDOSCOPE-ASSISTED VITREOUS SURGERY COMBINED WITH ATMOSPHERIC ENDOSCOPIC TECHNIQUE AND/OR SUBRETINAL ENDOSCOPIC TECHNIQUE FOR RHEGMATOGENOUS RETINAL DETACHMENT WITH GRADE C PROLIFERATIVE VITREORETINOPATHY.
    Kaga T; Yokoyama S; Kojima T; Mitamura H; Mori T; Matsuda T; Sato H; Yoshida N; Ichikawa K
    Retina; 2019 Jun; 39(6):1066-1075. PubMed ID: 29528982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The use of expansive gas in retinal detachment complicated by vitreoretinal proliferation].
    Ryckewaert M; Constantinides G; Pasquesoone H; Madelain F; Malot E
    Bull Soc Ophtalmol Fr; 1989 Nov; 89(11):1245-8. PubMed ID: 2630126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perfluorocarbon liquid in the management of retinal detachment with proliferative vitreoretinopathy.
    Coll GE; Chang S; Sun J; Wieland MR; Berrocal MH
    Ophthalmology; 1995 Apr; 102(4):630-8; discussion 638-9. PubMed ID: 7724180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Heavy tamponade in complicated inferior retinal detachment].
    Brunner M; Lang C; Valmaggia C
    Klin Monbl Augenheilkd; 2012 Apr; 229(4):407-10. PubMed ID: 22496014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
    Scott IU; Flynn HW; Murray TG; Feuer WJ;
    Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitreous substitutes and tamponades - A review of types, applications, and future directions.
    Shettigar MP; Dave VP; Chou HD; Fung A; Iguban E; March de Ribot F; Zabala C; Hsieh YT; Lalwani G
    Indian J Ophthalmol; 2024 Aug; 72(8):1102-1111. PubMed ID: 39078953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low viscosity liquid fluorochemicals in vitreous surgery.
    Chang S
    Am J Ophthalmol; 1987 Jan; 103(1):38-43. PubMed ID: 3799788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gelatinase B in proliferative vitreoretinal disorders.
    Abu El-Asrar AM; Dralands L; Veckeneer M; Geboes K; Missotten L; Van Aelst I; Opdenakker G
    Am J Ophthalmol; 1998 Jun; 125(6):844-51. PubMed ID: 9645722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The need for pharmacology in vitreoretinal surgery SOE Lecture 2007].
    Gandorfer A
    Klin Monbl Augenheilkd; 2007 Dec; 224(12):900-4. PubMed ID: 18260053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Vitreous surgery for intraocular proliferative disorders].
    Tano Y
    Nippon Ganka Gakkai Zasshi; 1991 May; 95(5):405-20. PubMed ID: 1872211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ["Introduction to heavy vitreous tamponades"].
    Helbig H; Joussen AM
    Klin Monbl Augenheilkd; 2009 Sep; 226(9):692. PubMed ID: 19750416
    [No Abstract]   [Full Text] [Related]  

  • 55. [Liquid perfluorocarbons in vitreo-retinal surgery].
    Benchekroun O; Lahbil D; Rachid R; Laaouissi N; Zaghloul K; Amraoui A
    J Fr Ophtalmol; 1998 Dec; 21(10):773-81. PubMed ID: 10052053
    [No Abstract]   [Full Text] [Related]  

  • 56. Fluid vitreous substitutes in vitreo retinal surgery.
    Saxena S; Gopal L
    Indian J Ophthalmol; 1996 Dec; 44(4):191-206. PubMed ID: 9251263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postoperative Perfluro-N-Octane tamponade for complex retinal detachment surgery.
    Reza AT
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):63-9. PubMed ID: 26415342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Capeans C; De Rojas MV; Lojo S; Salorio MS
    Retina; 1998; 18(6):546-50. PubMed ID: 9869464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erbium:YAG laser surgery of the vitreous and retina.
    Brazitikos PD; D'Amico DJ; Bernal MT; Walsh AW
    Ophthalmology; 1995 Feb; 102(2):278-90. PubMed ID: 7862415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.